Applied DNA Sciences (NASDAQ:APDN) will be posting its quarterly earnings results after the market closes on Thursday, December 28th. Analysts expect Applied DNA Sciences to post earnings of ($0.10) per share for the quarter.
Applied DNA Sciences (NASDAQ:APDN) opened at $1.60 on Wednesday. Applied DNA Sciences has a 52-week low of $0.90 and a 52-week high of $3.45. The company has a market capitalization of $42.98, a PE ratio of -3.27 and a beta of -0.60.
Several equities analysts recently commented on the company. ValuEngine cut Applied DNA Sciences from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. Maxim Group set a $5.00 price objective on Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, December 8th.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.